Alpha Tau Medical (DRTS) vs DENTSPLY SIRONA (XRAY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Alpha Tau Medical (DRTS) has outperformed DENTSPLY SIRONA (XRAY) over the past year, gaining 245.0% versus a loss of 30.7%. Over five years, DRTS leads with a +44.1% price change compared with -85.2% for XRAY. DENTSPLY SIRONA is the larger company by market cap ($1.70 billion vs $1.28 billion), about 1.3 times the size.
DENTSPLY SIRONA pays a dividend yielding 3.76%, while Alpha Tau Medical does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DRTS | XRAY |
|---|---|---|
| Share price | $13.85 | $8.51 |
| Market cap | $1.28B | $1.70B |
| 1-day change | -2.81% | -0.41% |
| YTD return | +187.88% | -25.28% |
| 1-year return | +245.04% | -30.74% |
| 5-year return | +44.08% | -85.24% |
| Forward P/E | — | 5.68 |
| EPS (TTM) | $-1.04 | $-2.73 |
| Dividend yield | 0.00% | 3.76% |
| Annual dividend | $0.00 | $0.32 |
| 52-week high | $15.79 | $14.76 |
| 52-week low | $3.43 | $8.38 |
| Distance from 52-week high | -12.29% | -42.38% |
| Analyst consensus | none | hold |
| Avg. price target upside | +28.52% | +57.55% |
| Average volume | 566.95K | 4.73M |
| Shares outstanding | 92.48M | 199.35M |
| Employees | 121 | 14,000 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- DRTS has outperformed XRAY by 275.8 percentage points over the past year.
- DENTSPLY SIRONA offers a meaningfully higher dividend yield (3.76% vs 0.00%).
About Alpha Tau Medical
DRTS stock →Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors.
Health Care · Medical/Dental Instruments · 121 employees
About DENTSPLY SIRONA
XRAY stock →DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide.
Health Care · Medical/Dental Instruments · 14,000 employees
DRTS vs XRAY FAQ
Which is bigger, Alpha Tau Medical or DENTSPLY SIRONA?
DENTSPLY SIRONA (XRAY) is larger, with a market capitalization of $1.70B compared with $1.28B for Alpha Tau Medical (DRTS).
Which stock has performed better over the past year, DRTS or XRAY?
DRTS returned +245.04% over the past 12 months, compared with -30.74% for XRAY (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Alpha Tau Medical or DENTSPLY SIRONA?
DENTSPLY SIRONA pays a dividend yielding 3.76%, while Alpha Tau Medical does not currently pay a regular dividend.
Are Alpha Tau Medical and DENTSPLY SIRONA in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.